MedTrace Logo

Pelvic Floor Muscle Training and Kaatsu Training for Women With Stress Urinary Incontinence

NCT02676700 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2018-02-22

No results posted yet for this study

Summary

This study examines the effect of adding so called Kaatsu training to pelvic floor muscle training. Half the participants will perform Kaatsu training on their thigh muscles followed by pelvic floor muscle training. The other half will receive pelvic floor muscle training alone.

Conditions

  • Urinary Stress Incontinence

Interventions

BEHAVIORAL

Pelvic floor muscle training and Kaatsu

The intervention includes three outpatient visits (weeks 0, 6 and 12) and between visits the participants perform PFMT and Kaatsu training as home training

BEHAVIORAL

Pelvic floor muscle training

The intervention includes three outpatient visits (weeks 0, 6 and 12) and between visits the participants perform PFMT as home training

Sponsors & Collaborators

  • Herlev Hospital

    lead OTHER

Principal Investigators

  • Ulla Due, PT, Ph.D · Department of Gynecology and Obstetrics, Herlev-Gentofte Hospital

  • Soren Gräs, MD · Department of Gynecology and Obstetrics, Herlev-Gentofte Hospital

  • Niels Klarskov, MD, lecturer · Department of Gynecology and Obstetrics, Herlev-Gentofte Hospital

  • Anders Vinther, PT, Ph.D. · Herlev-Gentofte hospital

  • Gunnar Lose, MD, Prof · Department of Gynecology and Obstetrics, Herlev-Gentofte Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2017-07-01
Completion
2017-08-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02676700 on ClinicalTrials.gov